Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women
Recent studies have identified the apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3B (APOBEC3B) as a source of mutations in various malignancies. APOBEC3B is overexpressed in several human cancer types, including breast cancer. In this study, we analyzed APOBEC3B mRNA expression in...
Main Authors: | , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5158016/ |
id |
pubmed-5158016 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-51580162016-12-21 Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women Tokunaga, Eriko Yamashita, Nami Tanaka, Kimihiro Inoue, Yuka Akiyoshi, Sayuri Saeki, Hiroshi Oki, Eiji Kitao, Hiroyuki Maehara, Yoshihiko Research Article Recent studies have identified the apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3B (APOBEC3B) as a source of mutations in various malignancies. APOBEC3B is overexpressed in several human cancer types, including breast cancer. In this study, we analyzed APOBEC3B mRNA expression in 305 primary breast cancers of Japanese women using quantitative reverse transcription-PCR, and investigated the relationships between the APOBEC3B mRNA expression and clinicopathological characteristics, prognosis, and TP53 mutations. The expression of APOBEC3B mRNA was detected in 277 tumors and not detected in 28 tumors. High APOBEC3B mRNA expression was significantly correlated with ER- and PR-negativity, high grade and high Ki67 index. The APOBEC3B mRNA expression was highest in the triple-negative and lowest in the hormone receptor-positive/HER2-negative subtypes. The TP53 gene was more frequently mutated in the tumors with high APOBEC3B mRNA expression. High APOBEC3B mRNA expression was significantly associated with poor recurrence-free survival in all cases and the ER-positive cases. These findings were almost consistent with the previous reports from the Western countries. In conclusion, high APOBEC3B mRNA expression was related to the aggressive phenotypes of breast cancer, high frequency of TP53 mutation and poor prognosis, especially in ER-positive tumors. Public Library of Science 2016-12-15 /pmc/articles/PMC5158016/ /pubmed/27977754 http://dx.doi.org/10.1371/journal.pone.0168090 Text en © 2016 Tokunaga et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Tokunaga, Eriko Yamashita, Nami Tanaka, Kimihiro Inoue, Yuka Akiyoshi, Sayuri Saeki, Hiroshi Oki, Eiji Kitao, Hiroyuki Maehara, Yoshihiko |
spellingShingle |
Tokunaga, Eriko Yamashita, Nami Tanaka, Kimihiro Inoue, Yuka Akiyoshi, Sayuri Saeki, Hiroshi Oki, Eiji Kitao, Hiroyuki Maehara, Yoshihiko Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women |
author_facet |
Tokunaga, Eriko Yamashita, Nami Tanaka, Kimihiro Inoue, Yuka Akiyoshi, Sayuri Saeki, Hiroshi Oki, Eiji Kitao, Hiroyuki Maehara, Yoshihiko |
author_sort |
Tokunaga, Eriko |
title |
Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women |
title_short |
Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women |
title_full |
Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women |
title_fullStr |
Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women |
title_full_unstemmed |
Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women |
title_sort |
expression of apobec3b mrna in primary breast cancer of japanese women |
description |
Recent studies have identified the apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3B (APOBEC3B) as a source of mutations in various malignancies. APOBEC3B is overexpressed in several human cancer types, including breast cancer. In this study, we analyzed APOBEC3B mRNA expression in 305 primary breast cancers of Japanese women using quantitative reverse transcription-PCR, and investigated the relationships between the APOBEC3B mRNA expression and clinicopathological characteristics, prognosis, and TP53 mutations. The expression of APOBEC3B mRNA was detected in 277 tumors and not detected in 28 tumors. High APOBEC3B mRNA expression was significantly correlated with ER- and PR-negativity, high grade and high Ki67 index. The APOBEC3B mRNA expression was highest in the triple-negative and lowest in the hormone receptor-positive/HER2-negative subtypes. The TP53 gene was more frequently mutated in the tumors with high APOBEC3B mRNA expression. High APOBEC3B mRNA expression was significantly associated with poor recurrence-free survival in all cases and the ER-positive cases. These findings were almost consistent with the previous reports from the Western countries. In conclusion, high APOBEC3B mRNA expression was related to the aggressive phenotypes of breast cancer, high frequency of TP53 mutation and poor prognosis, especially in ER-positive tumors. |
publisher |
Public Library of Science |
publishDate |
2016 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5158016/ |
_version_ |
1613783039166382080 |